Search
Displaying 21–30 of 1131 results
-
Jacksonville Vision Connection
- Sep 28, 2025
- 12:30 p.m. (EDT)
- 3601 Regent Blvd, Jacksonville, FL 32224
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering for the blind and low vision community.
-
Quarterly Vision Webinar – Thyroid Eye Disease (TED)
- Sep 20, 2025
- 12:00 p.m. (EDT)
- Virtual
Foundation EventJoin us to discuss understanding TED, its impact on vision, and current management options.
-
- Sep 20, 2025
- 9:00 a.m. (CDT)
- 4135 W. Lake Harriet Pkwy., Minneapolis, MN 55409
VisionWalkVisionWalk is a community-driven 5K walk that raises funds and awareness to support the Foundation Fighting Blindness in its mission to cure blinding retinal diseases.
-
Cincinnati - Northern Kentucky VisionWalk
- Sep 20, 2025
- 9:00 a.m. (EDT)
- 1135 Riverside Dr., Cincinnati, OH 45202
VisionWalkVisionWalk is a community-driven 5K walk that raises funds and awareness to support the Foundation Fighting Blindness in its mission to cure blinding retinal diseases.
-
The United in Vision 2026 conference unites two prestigious events—the Foundation Fighting Blindness VISIONS conference and the Retina International World Congress—into one extraordinary global gathering.
-
Letter to House Energy & Commerce Committee regarding H.R.1262, the Give Kids a Chance Act.
NewsOn behalf of the Foundation Fighting Blindness and the millions of Americans impacted by inherited retinal diseases (IRDs), we urge you to advance H.R.1262, the Give Kids a Chance Act, and reauthorize the Rare Pediatric Disease Priority Review Voucher (PRV) Program.
-
Give Kids a Chance: Reauthorizing a Lifeline for Children’s Vision
Foundation NewsThe House Energy & Commerce Committee is considering H.R.1262, the Give Kids a Chance Act, which would reauthorize the Rare Pediatric Disease Priority Review Voucher (PRV) Program.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2024 (July 1, 2024 – June 30, 2025)
-
Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial
Research NewsNACA is a gene-agnostic, oral medication designed to preserve vision in people with retinitis pigmentosa and Usher syndrome.
-
Recording Available: Insights Forum | Wednesday, August 27, 2025
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on August 27, 2025.
